Contract A207_PO-0443486-V3

The University of Virginia awarded contract A207_PO-0443486-V3 to Cell Signaling Technology Inc. on August 8, 2026, for the procurement of ACAT1 Antibody products. The contract specifies delivery to the Buyer and encompasses a total of 314 units at a cumulative contract value of $314, with a unit price of $1 per item. ACAT1 Antibody refers to monoclonal antibodies targeting Acetyl-Coenzyme A acetyltransferase 1, which are research reagents commonly utilized in laboratory and scientific applications.

This award represents a procurement action by a Virginia-based higher education institution for specialized research materials. The contract documents do not specify a defined performance period beyond the award date of August 8, 2026, nor do they identify a specific geographic place of performance. Cell Signaling Technology Inc. serves as the prime contractor responsible for fulfilling the antibody supply requirement. The modest cumulative contract value of $314 indicates a limited-scope procurement, likely representing routine replenishment of laboratory reagents for the University's research operations.